A Trippy Trial of Psilocybin for Depression

Do psychedelics treat mental illness? In this GameChanger episode host, Geoff Wall and guest, Sarah Grady, a psychiatric pharmacist, discuss a recent NEJM article comparing psilocybin (magic mushrooms) to escitalopram.

Guest:
Sarah Grady, PharmD
Drake University

Redeem your CPE or CME credit here with your GameChangers Subscription!

We want your feedback! Share your feedback and experience with GameChangers! https://www.jotform.com/build/90155144694964


References and resources:
Carhart-Harris R, Giribaldi B, Watts R, et al. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021 Apr 15;384(15):1402-1411. doi: 10.1056/NEJMoa2032994. PMID: 33852780.

Continuing Education Information:
Learning Objectives:
1. Discuss a recent study comparing psilocybin to escitalopram in depression
2. Identify potential patients that could benefit from psilocybin based on the study

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-231-H01-P
Initial release date: 8/3/21
Expiration date: 8/3/22
Dr. Sarah Grady reports no actual or potential conflicts of interest associated with this activity.
Complete CPE & CME details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram